Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy

DOI: 10.1080/2162402X.2015.1108511

Keywords: Cancer, dendritic cell, human, immunotherapy, phase I/II, renal cell carcinoma, RNA, survival, trial, vaccine

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text